[1]
Alexander-Curtis, M., Duan, J., Seeklander, A., Scott, S., Norton, N., Wong, C.L., Salman, S. and Verdoorn, T.A. 2017. Safety, tolerability and pharmacokinetic profile of recombinant human tissue kallikrein, DM199, after intravenous and subcutaneous administration in healthy volunteers. International Journal of Clinical Trials. 4, 4 (Oct. 2017), 139–146. DOI:https://doi.org/10.18203/2349-3259.ijct20174861.